Editor's Note

NOTE: This publication is brought to you by the publishers of Stockupticks.com and StockNight.com. The "Rapid Blast" service provides all the same great content you're used to in a text-based format that allows us to reach you in just minutes thereby maximizing your ability to READ, RESEARCH, and REACT. Today's profile highlights Pollution Research & Control Corp. (NASDAQ: PRCC)

Pollution Research and Control has the ability to identify dangerous toxins in short periods of time, a critical factor in personal, industrial, and commercial safety in this age of BioTerrorism. The company is uniquely positioned in the market of testing air and pollution particles and it's equipment can identify Anthrax and other ambient airborne threats. Like the canaries miners would lower into mine shafts to make sure the air was fit for human lungs, PRCC's products can protect mankind.

At present, the president and Congress are proposing that $3 billion be spent on various bioterror protection resources. The Associated Press is also reporting that senate aides say that 70 senators have already signed the bill.

Please take a moment to review this story. Just cut & paste this link:
http://www.thehealthchannel.com/reference/referencearticle.asp?docid=57801&co_id=&catID=20&rootcatID=20

About Pollution Research And Control Corp.

Exchange: NASDAQ Small Cap (PRCC)
Industry: Environmental Monitoring and Detection

PRCC manufactures and markets instrumentation used to detect and measure various types of pollution. PRCC also supplies computer controlled calibration systems that verify the accuracy of its instruments. Data loggers are used to collect and manage pollutant information and final reporting software for remote centralized applications.

Whether acid rain or city smog, PRCC keeps a log of pollution.

Through wholly owned subsidiary Dasibi Environmental, PRCC makes instruments that detect, measure, and monitor air pollution as well as related software for calibrating instruments and reporting data. PRCC's instruments measure levels of acid rain, ozone, smog, carbon monoxide, and other pollutants. The company sells to industrial manufacturers, government agencies, and education and research institutions. Foreign customers account for 85% of PRCC's sales and the company expects sales to China to make up the bulk of its future business.

---

A Quick Glance At The Numbers

Last Trade (12/7/01) 0.69
52 Week High 1.93
52 Week Low 0.20
Volume 41,900
Average Daily Volume (13wk) 70,400

---

We strongly encourage readers of this document to also review a report on PRCC by the E Street Journal, a Rapid Blast preferred content provider. It details historical instances of human exposure to Anthrax and discusses present governmental resolutions for Bio-Terrorism. We recommend reading this informative article from Headline to Disclosure.

**Just copy and paste this address into your browser location**

http://www.estreetjournal.net/e-street_2-14.php3

 

NEWS RELEASE - NEWS RELEASE - NEWS RELEASE

** THIS BREAKING NEWS WAS JUST RELEASED AT 7:55 am
Eastern Time Monday December 10, 2001 **

Press Release

SOURCE: Pollution Research and Control Corp.

Pollution Research and Control Corp. Announces Appointment of Leonard Makowka, M.D., Ph.D. as the Chief Scientific Advisor of the Company

LOS ANGELES, Dec. 10 /PRNewswire/ -- Pollution Research and Control Corporation (Nasdaq: PRCC - news), a leading diversified environmental and bio- technical monitoring device and technology company announces the appointment of Leonard Makowka, M.D., Ph.D. as the Chief Scientific Advisor. Dr. Makowka will work closely with Company CEO Jacques Tizabi in identifying and exploiting strategic growth opportunities at the corporate and product levels as well as attracting research and development grants.

``Dr. Makowka's diverse experience in the scientific and medical fields, along with his extensive network of relationships in the scientific business community, makes him an extremely valuable asset, as the Company accelerates its advances in the bio-med and bio-terrorism arena as well as other medical applications,'' says CEO Tizabi.

Makowka adds, "PRCC is poised to capitalize on significant growth opportunities in some of today's most dynamic sectors. I look forward to working with Mr. Tizabi and the Company's research and business development teams to pursue these opportunities aggressively."

Leonard Makowka, M.D., Ph.D. was previously the Chairman of the department of Surgery at Cedars Sinai Medical Center in Los Angeles. Over the last decade, he has been awarded more than $9 Million in research grants by prominent pharmaceutical companies and public health organizations, including the National Institute of Health (NIH). Dr. Makowka is a member of the Founders Circle of the Frist 2000 Roundtable established by U.S. Senator Bill Frist, co-author of the 2001 $3.2 Billion Senate Bio-Terrorism bill. Dr. Makowka is actively involved on numerous boards in the public, private and non-profit sectors, including the Board of Directors of Hollis Eden Pharmaceuticals. Dr. Makowka is a frequent invited speaker at professional conferences and symposia and has authored or co-authored more than 350 medical and scientific journal articles.

SAFE HARBOR STATEMENT: Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's actual results in the future to differ materially from forecasted results. These risks and uncertainties include, among other things, product price volatility, product demand, market competition and risk inherent in the operations of a company.

For further information please contact: Jacques Tizabi, CEO of Pollution Research and Control Corp., 310-248-3655

SOURCE: Pollution Research and Control Corp.

For all the current news on PRCC, please cut & paste this link:

http://finance.yahoo.com/q?s=prcc&d=v1

Company Contact

506 Paula Avenue
Glendale CA 91201
Phone: (818) 247-7601
Fax: (818) 247-7614
Web Site: http://www.dasibi.com
Employees: 50

---

Safe Harbor Statement: Statements contained in this document, including those pertaining to estimates and related plans other than statements of historical fact, are forward-looking statements subject to a number of uncertainties that could cause actual results to differ materially from statements made.

Disclaimer: Rapid Blast is a property of Market Pathways Financial Relations Incorporated (MP). The information, opinions and analysis contained herein are based on sources believed to be reliable but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. This report is for information purposes only and should not be used as the basis for any investment decision. MP has been compensated with $10,000 by Corporate Image Bureau (E Street Journal) for advertising services including preparation and distribution of this report and additional distributions and services at a later time. This constitutes a conflict of interest as to MP's ability to remain objective in its communication regarding the subject company. Write or call MP for detailed disclosure as required by Rule 17b of the Securities Act of 1933/1934. MP is not an investment advisor and this report is not investment advice. This information is neither a solicitation to buy nor an offer to sell securities. Information contained herein contains forward-looking statements and is subject to significant risks and uncertainties, which will affect the results. The opinions contained herein reflect our current judgment and are subject to change without notice. MP and/or its affiliates, associates and employees from time to time may have either a long or short position in securities mentioned. Information contained herein may not be reproduced in whole or in part without the express written consent of Market Pathways Financial Relations Incorporated.